The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Healthcare IPOs image Healthcare IPOs » By The Online Investor Staff, updated Tue., Mar. 19, 4:36 AM
Recent initial public offerings in the Healthcare IPOs category.

Slide #1. Fulgent Genetics Initial Public Offering

Company: Fulgent Genetics
Proposed Symbol: FLGT
Shares Offered: 4,200,000
Price Per Share: $9.00
Over-Allotment: 630,000
Description: Fulgent Genetics announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a public offering price of $9.00 per share, before underwriting discounts and commissions. Fulgent Genetics has granted the underwriters a 30-day option to purchase up to an additional 630,000 shares from the company at the same price. The shares are expected to begin trading on The NASDAQ Global Market on September 29, 2016, under the ticker symbol "FLGT." The offering is expected to close on October 4, 2016, subject to customary closing conditions.

IPOs: Fulgent Genetics

List of Healthcare IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Regulus Therapeutics Inc.               RGLS      10/4/2012
Enanta Pharmaceuticals, Inc             ENTA      3/21/2013
Atossa Genetics, Inc.                   ATOS      11/8/2012
Zoetis                                  ZTS       
Chimerix, Inc.                          CMRX      4/11/2013
PTC Therapeutics, Inc.                  PTCT      
bluebird bio, Inc.                      BLUE      6/19/2013
Prosensa Holding B.V.                   RNA       
Agios Pharmaceuticals, Inc.             AGIO      
Onconova Therapeutics, Inc.             ONTX      
Veracyte, Inc.                          VCYT      
Evoke Pharma, Inc.                      EVOK      
GlycoMimetics, Inc.                     GLYC      
Karyopharm Therapeutics Inc.            KPTI      
Tandem Diabetes Care                    TNDM      
MacroGenics, Inc                        MGNX      
Trevena, Inc.                           TRVN      
Xencor                                  XNCR      
ADMA Biologics                          ADMA      
Cara Therapeutics                       CARA      
Inogen, Inc.                            INGN      
Ultragenyx Pharmaceutical Inc.          RARE      
Intra-Cellular Therapies                ITCI      
Biocept, Inc.                           BIOC      
uniQure B.V.                            QURE      
Revance Therapeutics                    RVNC      
Eagle Pharmaceuticals                   EGRX      
Akebia Therapeutics                     AKBA      
Semler Scientific, Inc.                 SMLR      2/21/2014
Phibro Animal Health Corporation        PAHC      
Galmed Pharmaceuticals                  GLMD      
Agile Therapeutics, Inc.                AGRX      
MediWound Ltd                           MDWD      
SCYNEXIS                                SCYX      
Phibro Animal Health Corporation        PAHC      
Aldeyra Therapeutics                    ALDX      
Lantheus Holdings, Inc.                 LNTH      
Amphastar Pharmaceuticals, Inc.         AMPH      
Adeptus Health, Inc.                    ADPT      
Karyopharm Therapeutics Inc.            KPTI      
Affimed                                 AFMD      
Minerva Neurosciences, Inc.             NERV      
IRadimed Corporation                    IRMD      
SAGE Therapeutics, Inc                  SAGE      
Ocular Therapeutix                      OCUL      
Catalent, Inc.                          CTLT      
Marinus Pharmaceuticals, Inc.           MRNS      
T2 Biosystems, Inc.                     TTOO      
Cellectar Biosciences, Inc.             CLRB      
ProQR Therapeutics                      PRQR      
Dermira                                 DERM      
Atara Biotherapeutics, Inc.             ATRA      
Xenon Pharmaceuticals Inc.              XENE      
Nevro                                   NVRO      
Coherus BioSciences, Inc.               CHRS      
Check-Cap Ltd.                          CHEK      2/19/2015
Ascendis Pharma A/S                     ASND      
OpGen                                   OPGN      
 Summit Therapeutics plc                SMMT      
Blueprint Medicines Corporation         BPMC      
Cellectis                               CLLS      
aTyr Pharma, Inc.                       LIFE      
Xbiotech                                XBIT      
Cidara Therapeutics, Inc.               CDTX      
Viking Therapeutics, Inc.               VKTX      
Adaptimmune Therapeutics plc            ADAP      
Collegium Pharmaceutical, Inc.          COLL      
Glaukos Corporation                     GKOS      
Teladoc                                 TDOC      
Glaukos Corporation                     GKOS      
Seres Therapeutics, Inc.                MCRB      
vTv Therapeutics Inc.                   VTVT      
Benitec Biopharma Limited               BNTC      
REGENXBIO Inc.                          RGNX      
Penumbra, Inc.                          PEN       
NovoCure Limited                        NVCR      
Aclaris Therapeutics, Inc.              ACRS      
CytomX Therapeutics, Inc.               CTMX      
WAVE Life Sciences Ltd.                 WVE       
Mesoblast Limited                       MESO      
BeiGene, Ltd.                           BGNE      
Editas Medicine, Inc.                   EDIT      
Syndax Pharmaceuticals, Inc.            SNDX      
Corvus Pharmaceuticals, Inc.            CRVS      
Intellia Therapeutics, Inc.             NTLA      
Pulse Biosciences, Inc.                 PLSE      
Merus B.V.                              MRUS      
Clearside Biomedical, Inc.              CLSD      
Syros Pharmaceuticals                   SYRS      
Tactile Systems Technology, Inc.        TCMD      
Medpace Holdings, Inc.                  MEDP      
Fulgent Genetics                        FLGT      

March 19, 2024    4:36 AM Eastern

Healthcare IPOs | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.